A genus of Gram-positive, obligate anaerobic bacteria within the lachnospiraceae family that produces short chain fatty acids and plays a significant role in bile acid metabolism. Key species include B. obeum, B. wexlerae, B. hydrogenotrophica, and B. producta. While primarily a beneficial commensal, Blautia shows context-dependent behavior with some species enriched in specific disease states.
SCFA Production and Bile Acid Metabolism
- Produces acetate as its primary fermentation end-product, with some species also generating butyrate and propionate.
- B. hydrogenotrophica is a unique acetogen that converts H2 and CO2 into acetate via the Wood-Ljungdahl pathway, providing a critical hydrogen sink in the gut ecosystem.
- Active in bile acid transformation: deconjugation via bile salt hydrolase (BSH) activity and downstream secondary bile acid modifications. This places Blautia at the intersection of lipid metabolism and gut-liver axis signaling.
- Bile acid metabolism by Blautia affects FXR and TGR5 receptor signaling, influencing cholesterol homeostasis, glucose metabolism, and inflammation.
Disease Associations
Depleted in Disease
- IBD: B. obeum depleted in Crohn's disease and ulcerative colitis; its loss reduces SCFA-mediated mucosal protection.
- Colorectal cancer: reduced in CRC patients alongside other lachnospiraceae members.
- Carotid atherosclerosis: part of the depleted SCFA-producing network in subclinical CVD [1].
Enriched in Disease (Context-Dependent)
- Multiple sclerosis: some Blautia species are paradoxically increased in MS patients, potentially reflecting a compensatory shift or pro-inflammatory capacity in the neuroinflammatory context [2].
- Endometriosis: Blautia abundance altered by hormonal treatment in endometriosis patients, suggesting sensitivity to estrogen-modulating therapies [3].
Role in Gut Ecosystem
- Functions as a metabolic hub connecting fiber fermentation, bile acid cycling, and gas metabolism.
- Hydrogen consumption by B. hydrogenotrophica prevents H2 accumulation that would thermodynamically inhibit fiber fermentation by other bacteria.
- Cross-feeds with butyrate producers: acetate from Blautia serves as a substrate for butyryl-CoA:acetate CoA-transferase in roseburia and faecalibacterium prausnitzii, enabling butyrate production.
- The genus occupies a middle trophic level in the colonic food web, connecting primary fiber degraders (ruminococcus R. bromii) to terminal butyrate producers.
Metal Sensitivity
- As a lachnospiraceae member, Blautia shares the family-wide sensitivity to heavy metal stress.
- Iron-sulfur cluster enzymes in the Wood-Ljungdahl pathway of acetogenic species are particularly vulnerable to metal disruption.
- cadmium and lead exposure depletes Blautia alongside other SCFA producers in the gut metal microbiome framework.
Key Metabolites
- Acetate — primary fermentation product; substrate for butyrate producers.
- Bile acid derivatives — BSH-mediated deconjugation and secondary bile acid production.
- Hydrogen consumption — acetogenic species convert H2/CO2 to acetate, regulating gut gas homeostasis.
Key Sources
Connections
- lachnospiraceae — parent family; Blautia is a core member genus
- roseburia — metabolic cross-feeding: Blautia acetate feeds Roseburia butyrate production
- faecalibacterium prausnitzii — complementary SCFA producer; co-depleted in disease
- multiple sclerosis — paradoxically enriched in some MS studies; context-dependent effects
- endometriosis — altered by hormonal treatment in endometriosis
- cardiovascular disease — depleted in subclinical atherosclerosis; bile acid metabolism relevant to CVD
- colorectal cancer — depleted alongside other Lachnospiraceae in CRC
- iron — Fe-S clusters in acetogenic pathway vulnerable to metal competition
- dysbiosis — depletion accompanies loss of other SCFA producers
- inflammation — bile acid metabolism modulates FXR/NF-kB inflammatory signaling
- gut metal microbiome — sensitive to heavy metal perturbation as Lachnospiraceae member